Literature DB >> 24099021

Hepatotoxicity of antibiotics: a review and update for the clinician.

Jonathan G Stine1, James H Lewis.   

Abstract

Collectively, the various classes of antibiotics are a leading cause of drug-induced liver injury (DILI). However, acute antibiotic-associated DILI can be difficult to diagnose, as the course of therapy is usually brief, and other confounding factors are often present. In addition to the broad clinicopathologic spectrum of hepatotoxicity associated with the antimicrobials, the underlying infectious disease being treated may itself be associated with hepatic dysfunction and jaundice. This review provides summarized information on several classes of antimicrobial agents, highlighting new agents causing DILI and updating information on older agents.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibiotics; Drug safety; Drug-induced liver injury; Monitoring

Mesh:

Substances:

Year:  2013        PMID: 24099021     DOI: 10.1016/j.cld.2013.07.008

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  10 in total

1.  Hepatic decompensation likely attributable to simeprevir in patients with advanced cirrhosis.

Authors:  Jonathan G Stine; Nicolas Intagliata; Neeral L Shah; Curtis K Argo; Stephen H Caldwell; James H Lewis; Patrick G Northup
Journal:  Dig Dis Sci       Date:  2014-11-06       Impact factor: 3.199

2.  Synthesis, Spectroscopic Studies for Five New Mg (II), Fe (III), Cu (II), Zn (II) and Se (IV) Ceftriaxone Antibiotic Drug Complexes and Their Possible Hepatoprotective and Antioxidant Capacities.

Authors:  Samy M El-Megharbel; Safa H Qahl; Fatima S Alaryani; Reham Z Hamza
Journal:  Antibiotics (Basel)       Date:  2022-04-20

3.  Fungal Infection in Acutely Decompensated Cirrhosis Patients: Value of Model for End-Stage Liver Disease Score.

Authors:  Shahid Habib; Sandeep Yarlagadda; Teresia A Carreon; Lindsey M Schader; Chiu-Hsieh Hsu
Journal:  Gastroenterology Res       Date:  2020-10-31

4.  How I treat hepatitis C virus infection in patients with hematologic malignancies.

Authors:  Harrys A Torres; George B McDonald
Journal:  Blood       Date:  2016-07-21       Impact factor: 22.113

Review 5.  Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.

Authors:  Jonathan G Stine; James H Lewis
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-12-25       Impact factor: 3.869

6.  Penicillin-induced liver injury during treatment for ocular neurosyphilis.

Authors:  Janelle Wilkinson; Abir Zainal; Syed Yaseen Naqvi
Journal:  BMJ Case Rep       Date:  2016-07-07

7.  A comparison of estimators from self-controlled case series, case-crossover design, and sequence symmetry analysis for pharmacoepidemiological studies.

Authors:  Yoshinori Takeuchi; Tomohiro Shinozaki; Yutaka Matsuyama
Journal:  BMC Med Res Methodol       Date:  2018-01-08       Impact factor: 4.615

Review 8.  Drug-induced liver injury: Do we know everything?

Authors:  Tamara Alempijevic; Simon Zec; Tomica Milosavljevic
Journal:  World J Hepatol       Date:  2017-04-08

Review 9.  Setting the Beta-Lactam Therapeutic Range for Critically Ill Patients: Is There a Floor or Even a Ceiling?

Authors:  Erin F Barreto; Andrew J Webb; Gwendolyn M Pais; Andrew D Rule; Paul J Jannetto; Marc H Scheetz
Journal:  Crit Care Explor       Date:  2021-06-11

10.  Evaluation of Possible Genotoxic Activity of Dirithromycin in Cultured Human Lymphocytes.

Authors:  Ahmet Kayraldız; Lale Dönbak; Ayşe Yavuz Kocaman; Esra Köker; Şule Gökçe
Journal:  J Toxicol       Date:  2015-10-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.